141 related articles for article (PubMed ID: 34453533)
1. Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
Birgy A; Madhi F; Jung C; Levy C; Cointe A; Bidet P; Hobson CA; Bechet S; Sobral E; Vuthien H; Ferroni A; Aberrane S; Cuzon G; Beraud L; Gajdos V; Launay E; Pinquier D; Haas H; Desmarest M; Dommergues MA; Cohen R; Bonacorsi S;
J Antimicrob Chemother; 2021 Oct; 76(11):2839-2846. PubMed ID: 34453533
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial.
Stewart AG; Bauer MJ; Butkiewicz D; Hinton A; Henderson A; Harris PNA; Paterson DL
Int J Antimicrob Agents; 2023 Aug; 62(2):106858. PubMed ID: 37211261
[TBL] [Abstract][Full Text] [Related]
3. Effective Oral Combination Treatment for Extended-Spectrum Beta-Lactamase-Producing
Al-Tamimi M; Abu-Raideh J; Albalawi H; Shalabi M; Saleh S
Microb Drug Resist; 2019 Oct; 25(8):1132-1141. PubMed ID: 31107146
[No Abstract] [Full Text] [Related]
4. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Lampri N; Galani I; Poulakou G; Katsarolis I; Petrikkos G; Giamarellou H; Souli M
J Antimicrob Chemother; 2012 Oct; 67(10):2424-8. PubMed ID: 22665388
[TBL] [Abstract][Full Text] [Related]
5. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
Skarp KP; Shams A; Montelin H; Lagerbäck P; Tängdén T
Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958
[TBL] [Abstract][Full Text] [Related]
6. A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
Birgy A; Delecourt M; Geslain G; Desselas E; Caseris M; Magnan M; Mariani-Kurkdjian P; Bidet P; Bonacorsi S
J Antimicrob Chemother; 2017 Jul; 72(7):1911-1914. PubMed ID: 28369441
[TBL] [Abstract][Full Text] [Related]
7.
Gupta A; Malik S; Kaminski M; Landman D; Quale JM
Microb Drug Resist; 2022 Apr; 28(4):419-424. PubMed ID: 35451880
[TBL] [Abstract][Full Text] [Related]
8. Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.
Lignieres G; Birgy A; Jung C; Bonacorsi S; Levy C; Angoulvant F; Grimprel E; Dommergues MA; Gillet Y; Craiu I; Rybak A; De Pontual L; Dubos F; Cixous E; Gajdos V; Pinquier D; Andriantahina I; Soussan-Banini V; Georget E; Launay E; Vignaud O; Cohen R; Madhi F
PLoS One; 2021; 16(9):e0257217. PubMed ID: 34529722
[TBL] [Abstract][Full Text] [Related]
9. Results from a Prospective
Fuchs F; Hamprecht A
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917983
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280
[TBL] [Abstract][Full Text] [Related]
11. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
Pal RB; Pal P; Jain S; Kulkarni KP
J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
[TBL] [Abstract][Full Text] [Related]
14. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.
Søraas A; Sundsfjord A; Jørgensen SB; Liestøl K; Jenum PA
PLoS One; 2014; 9(1):e85889. PubMed ID: 24454943
[TBL] [Abstract][Full Text] [Related]
15. Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI).
Tverring J; Månsson E; Andrews V; Ljungquist O
Trials; 2023 Sep; 24(1):568. PubMed ID: 37660037
[TBL] [Abstract][Full Text] [Related]
16. Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Thelen H; Dilworth TJ; Mercier RC
Chemotherapy; 2022; 67(4):261-268. PubMed ID: 36417841
[TBL] [Abstract][Full Text] [Related]
17. Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.
Cohen Stuart J; Leverstein-Van Hall M; Kortmann W; Verlind J; Mulder F; Scharringa J; Fluit A; Ekkelenkamp M
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):2021-2025. PubMed ID: 30117050
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United States.
Asempa TE; Bobenchik AM; Bourassa L; Clark AE; Hatch MT; Huse HK; Martin IW; Mochon AB; Munson E; Sfeir MM; Srodon M; Wang Y; Nicolau DP
Int J Antimicrob Agents; 2023 Mar; 61(3):106733. PubMed ID: 36690122
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children].
François P; Croizé J; Bost C; Wollschlager K
Arch Pediatr; 1995 Feb; 2(2):136-42. PubMed ID: 7735445
[TBL] [Abstract][Full Text] [Related]
20. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
Livermore DM; Hope R; Mushtaq S; Warner M
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():189-93. PubMed ID: 18154546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
